缺血预处理调节的 miR-21 通过其靶标 PDCD4 抗细胞凋亡作用保护心脏免受缺血/再灌注损伤。
Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4.
机构信息
RNA and Cardiovascular Research Laboratory, Department of Anesthesiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, MSB-E548, Newark, NJ 07101, USA.
出版信息
Cardiovasc Res. 2010 Aug 1;87(3):431-9. doi: 10.1093/cvr/cvq082. Epub 2010 Mar 10.
AIMS
The aims of the present study are to determine the miRNA expression signature in rat hearts after ischaemic preconditioning (IP) and to identify an IP-regulated miRNA, miR-21, in IP-mediated cardiac protection, and the potential cellular and molecular mechanisms involved.
METHODS AND RESULTS
The miRNA expression signature was investigated in rat hearts. Among the 341 arrayed miRNAs, 40 miRNAs were differentially expressed (21 up and 19 down) in rat hearts with IP, compared with their controls. Some of these differentially expressed miRNAs were further verified by quantitative reverse transcriptase-polymerase chain reaction. Remarkably, miR-21 was one of most upregulated miRNAs in hearts after IP. In vivo, IP-mediated cardiac protection against ischaemia/reperfusion injury was inhibited by knockdown of cardiac miR-21. In cultured cardiac myocytes, we identified that miR-21 also had a protective effect on hypoxia/reoxygenation-induced cell apoptosis that was associated with its target gene, programmed cell death 4. The protective effect of miR-21 on cardiac cell apoptosis was further confirmed in rat hearts after ischaemia/reperfusion injury in vivo.
CONCLUSION
The results suggest that miRNAs are involved in IP-mediated cardiac protection. Identifying the roles of IP-regulated miRNAs in cardiac protection may provide novel therapeutic and preventive targets for ischaemic heart disease.
目的
本研究旨在确定缺血预处理(IP)后大鼠心脏中的 miRNA 表达谱,并鉴定出在 IP 介导的心脏保护中起作用的 IP 调节 miRNA,即 miR-21,以及涉及的潜在细胞和分子机制。
方法和结果
研究调查了大鼠心脏中的 miRNA 表达谱。在 341 个排列的 miRNA 中,与对照组相比,IP 处理的大鼠心脏中有 40 个 miRNA 表达存在差异(21 个上调,19 个下调)。其中一些差异表达的 miRNA 通过定量逆转录聚合酶链反应进一步验证。值得注意的是,miR-21 是 IP 后心脏中上调最明显的 miRNA 之一。在体内,通过敲低心脏 miR-21 抑制了 IP 介导的对缺血/再灌注损伤的心脏保护作用。在培养的心肌细胞中,我们还发现 miR-21 对缺氧/复氧诱导的细胞凋亡也具有保护作用,这与其靶基因程序性细胞死亡 4 有关。miR-21 对心脏细胞凋亡的保护作用在体内缺血/再灌注损伤后的大鼠心脏中得到了进一步证实。
结论
结果表明 miRNA 参与了 IP 介导的心脏保护。鉴定 IP 调节的 miRNA 在心脏保护中的作用可能为缺血性心脏病提供新的治疗和预防靶点。
相似文献
Cardiovasc Res. 2010-8-1
J Cardiovasc Pharmacol Ther. 2016-5
Am J Physiol Heart Circ Physiol. 2014-5-23
引用本文的文献
MedComm (2020). 2025-6-16
Am J Cardiovasc Drugs. 2024-1
本文引用的文献
J Mol Cell Cardiol. 2009-1-27
Proc Natl Acad Sci U S A. 2008-9-2
IUBMB Life. 2008-4